Healthcare -
Biotechnology - NASDAQ - US
$ 2.33
0.431 %
$ 117 M
Market Cap
-1.22
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
scPharmaceuticals Inc.
| Revenue | 36.3 M |
| Cost Of Revenue | 11.4 M |
| Gross Profit | 25 M |
| Operating Expenses | 89.7 M |
| Operating Income | -64.8 M |
| Other Expenses | 20.4 M |
| Net Income | -85.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 36.3 | 13.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 11.4 | 3.8 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 5 K | 4 K |
| Gross Profit | 25.0 | 9.8 | (0.5) | (0.4) | (0.4) | (0.4) | (0.3) | (0.2) | 5 K | 4 K |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 89.7 | 65.2 | 36.2 | 25.8 | 29.9 | 32.9 | 29.7 | 23.4 | 17.9 | 10.8 |
| Selling, General and Administrative Expenses | 77.6 | 53.4 | 20.6 | 9.8 | 11.8 | 8.3 | 13.7 | 9.1 | 6.1 | 2.6 |
| Research and Development Expenses | 12.1 | 11.8 | 15.5 | 16.0 | 18.1 | 24.6 | 15.9 | 14.3 | 11.9 | 8.3 |
| Operating Income | (64.8) | (55.4) | (36.2) | (25.8) | (29.9) | (32.9) | (29.7) | (23.4) | (17.9) | (10.8) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 7.6 | 8.1 | 3.3 | 2.6 | 2.6 | 1.8 | 1.4 | 0.8 | 6.5 | 0 |
| Total Other Income | (20.4) | 0.6 | (0.7) | (2.2) | (2.3) | 91 K | 0.2 | (0.4) | (6.5) | 0.3 |
| Pre-Tax Income | (85.1) | (54.8) | (36.8) | (28.0) | (32.2) | (33.0) | (29.4) | (23.8) | (24.4) | (10.5) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | 0 | 0.7 | 2.5 | 2.2 | 1.4 | (0.2) | 0.4 | 6.5 | (0.3) |
| Net Income | (85.1) | (54.8) | (37.5) | (30.5) | (34.4) | (34.4) | (29.4) | (23.8) | (24.4) | (10.5) |
| EPS | 1.91 | 1.42 | 1.32 | 1.11 | 1.4 | 1.85 | 1.59 | 8.04 | 2.18 | 0.94 |